UBS Downgrades Newmont to Neutral, Lowers Price Target to $53
UBS analyst Cleve Rueckert downgrades Newmont (NYSE:NEM) from Buy to Neutral and lowers the price target from $59 to $53.
UBS Downgrades Zenvia to Neutral, Lowers Price Target to $1.3
UBS analyst Leonardo Olmos downgrades Zenvia (NASDAQ:ZENV) from Buy to Neutral and lowers the price target from $11 to $1.3.
Wolfe Research Downgrades Qualys to Peer Perform
Wolfe Research analyst Joshua Tilton downgrades Qualys (NASDAQ:QLYS) from Outperform to Peer Perform.
Argus Research Downgrades Church & Dwight Co to Hold
Argus Research downgrades Church & Dwight Co (NYSE:CHD) from Buy to Hold.
Cowen & Co. Downgrades Capri Holdings to Market Perform, Lowers Price Target to $55
Cowen & Co. analyst Oliver Chen downgrades Capri Holdings (NYSE:CPRI) from Outperform to Market Perform and lowers the price target from $70 to $55.
Piper Sandler Downgrades Kingstone Companies to Neutral, Lowers Price Target to $1.6
Piper Sandler analyst Paul Newsome downgrades Kingstone Companies (NASDAQ:KINS) from Overweight to Neutral and lowers the price target from $2.45 to $1.6.
Piper Sandler Downgrades Heritage Insurance Hldgs to Neutral, Lowers Price Target to $2.2
Piper Sandler analyst Nicole Miller Regan downgrades Heritage Insurance Hldgs (NYSE:HRTG) from Overweight to Neutral and lowers the price target from $4.3 to $2.2.
JP Morgan Downgrades Syneos Health to Underweight, Lowers Price Target to $28
JP Morgan analyst Casey Woodring downgrades Syneos Health (NASDAQ:SYNH) from Neutral to Underweight and lowers the price target from $30 to $28.
Morgan Stanley Downgrades XPO to Equal-Weight, Lowers Price Target to $43
Morgan Stanley analyst Ravi Shanker downgrades XPO (NYSE:XPO) from Overweight to Equal-Weight and lowers the price target from $55 to $43.
Morgan Stanley Downgrades Saia to Underweight, Raises Price Target to $230
Morgan Stanley analyst Ravi Shanker downgrades Saia (NASDAQ:SAIA) from Equal-Weight to Underweight and raises the price target from $188 to $230.